BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
search help

Documents 1-25 out of 38 found
  Current Search:  relpax: 139, eletriptan: 129, hydrobromide: 107  

100%
TEXT
http://www.fda.gov/cder/orange/appendix_a.txt
4, ACETAMINOPHEN PHENAPHEN-650 W/ CODEINE, ACETAMINOPHEN PHENAZINE, PHENDIMETRAZINE TARTRATE PHENAZINE-35, PHENDIMETRAZINE TARTRATE PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE PHENERGAN FORTIS, PROMETHAZINE HYDROCHLORIDE PHENERGAN PLAIN, PROMETHAZINE HYDROCHLORIDE PHENERGAN VC W/ CODEINE, CODEINE PHOSPHATE PHENERGAN VC, PHENYLEPHRINE HYDROCHLORIDE PHENERGAN W/ CODEINE, CODEINE...

Matching: relpax eletriptan hydrobromide Find similar documents More document info
100%
HTML
NMEs Approved in CY 2002
NMEs Approved in Calendar Year 2002 - NDA Number Generic Name Trade Name Dosage Form Applicant *Classification Approval Date 21-232 Nitisinone Orfadin Capsule Swedish Orphan -- 1PV 01-18-2002 21-286 Olmesartan Medoxomil Benicar Tablet Sankyo- 1S 04-25-2002 21-344 Fulvestrant Faslodex Injection AstraZeneca 1S 04-25-2002 21-272 Treprostinil Sodium Remodulin Injection United...
author: Susan Daugherty
Matching: relpax eletriptan hydrobromide Find similar documents More document info
100%
HTML
Prescription and Over-the-Counter Drug Product List: 3/2003
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE; ORAL FIORICET W/ CODEINE -D- AB + NOVARTIS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN -A- AB + WATSON PHARMS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN ACETAMINOPHEN; CODEINE PHOSPHATE TABLET; ORAL CODRIX -A- + ANDRX PHARMS 500MG;30MG N40441 001...
author: AUTHOR
Matching: relpax eletriptan hydrobromide Find similar documents More document info
100%
HTML
Prescription and OTC Drug Product List 12/2002
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACARBOSE TABLET; ORAL PRECOSE -D- BAYER 25MG N20482 004 MAY 29, 1997 DEC CAHN -D- 50MG N20482 001 SEP 06, 1995 DEC CAHN -D- + 100MG N20482 002 SEP 06, 1995 DEC CAHN -A- BAYER PHARMS 25MG N20482 004 MAY 29, 1997 DEC CAHN -A- 50MG N20482 001 SEP 06, 1995 DEC CAHN -A- + 100MG N20482 002 SEP 06, 1995 DEC CAHN ACYCLOVIR -A- CREAM;...
Matching: relpax eletriptan hydrobromide Find similar documents More document info
67%
HTML
FDA Drug Approvals List October 1999
Application #: 020156 Efficacy Supplement#: 022 Type: SE2 to Original New Drug Application Approval Date: 28-OCT-99 Trade Name: VIDEX Dosage Form: POWDER, FOR RECONSTITUTION Applicant: BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE Active Ingredient(s): DIDANOSINE OTC/RX Status: RX Efficacy Claim:Provides for a new strength as well as allowing a change in dosing interval...
Matching: eletriptan hydrobromide Find similar documents More document info
66%
HTML
Triptans (serotonin receptor agonists) for migraine headaches - [Medication] - Quest Diagnostics Patient Health Library
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Triptans (serotonin receptor agonists) for migraine headaches - [Medication] - Quest Diagnostics Patient Health Library Triptans (serotonin receptor agonists) for migraine headaches - [Medication] - Quest Diagnostics Patient Health Library Brain and nerves,...
Matching: relpax eletriptan Find similar documents More document info
66%
HTML
Neurogen Corporation
- - - - - - - Thomas A.
At Milbank, Steve focused on transactions which raised capital in public and private markets for established companies, as well as the formation of numerous joint ventures and alliances.
James E.
He began his career at Ciba-Geigy as a Senior Scientist and also spent two years as Scientific Director at Franklin Diagnostics.
Charles is the architect...
Matching: relpax eletriptan Find similar documents More document info
66%
HTML
BioPortfolio Limited
Many companies could benefit from assessing their existing delivery technologies in other therapeutic areas, such as diabetes (needle-free injections, inhaled insulins), HRT (sustained-release patch technology) and others 10 CHAPTER 2 INTRODUCTION AND SCOPE 21 Disease overview 21 Etiology 21 Diagnosis and classification of migraine 22 Migraine diagnosis 22 Patient history and diaries...
Matching: relpax eletriptan Find similar documents More document info
66%
HTML
Database R
R - investigational drugs, therapies and- vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products To purchase documents on-line click on -link attached to selected document!- The fee is $15 per document Documents are delivered by e-mail...
Matching: relpax eletriptan Find similar documents More document info
66%
HTML
Database E
E - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products To purchase documents on-line click on- link attached to selected document!- The fee is $15 per document Documents are delivered by e-mail...
Matching: relpax eletriptan Find similar documents More document info
66%
HTML
Drug Approval Package
FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Relpax (Eletriptan) Tablets Company:- Pfizer Inc
Application No.:- 021016 Approval Date:-12/26/2002 Approval Letter(s) - - Printed Labeling - - Medical Review(s) Part 1 - Part 2 - Part 3 - Part 4 - Chemistry Review(s) - - Pharmacology Review(s) Part 1 - Part 2 - - Clinical...
Matching: relpax eletriptan Find similar documents More document info
66%
HTML
CDER 2002 Report to the Nation; Drug Review
Food and Drug Administration • Center for Drug Evaluation and Research About CDER - Report Search CDER Report to the Nation: 2002 Table of Contents Adobe Acrobat version of this document 1 Drug Review Index Mission Highlights New Drug Review List of priority new drugs List of new molecular entities List of orphan new drugs New Drug Review Statistics Priority new drug statistics...
author: OLIVERN
Matching: Find similar documents More document info
66%
HTML
FY 2003 NDA Approvals for New Molecular Entities
FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -FY 2003 NDA Approvals for New Molecular Entities as of September 30, 2003 NDA # Trade Name (Generic Name) Dosage Form Applicant Date of- Approval Class Indication(s) 21-445 Zetia------ (ezetimibe)-- Tablets MSP Singapore -25-Oct-02 1S Zetia is indicated for (1) Primary hypercholesterolemia ...
Matching: relpax eletriptan Find similar documents More document info
66%
PDF
Zomig NS AP Ltr Sep 30.doc
Rev 09/ 03 SIC Rx only ZOMIG (zolmitriptan) Nasal Spray For Nasal Use Only DESCRIPTION ZOMIG ® (zolmitriptan) Nasal Spray contains zolmitriptan, which is a selective 5- hydroxytryptamine 1B/ 1D (5- HT 1B/ 1D ) receptor agonist
ZOMIG should not be given to patients with cerebrovascular syndromes including (but not limited to) stroke of any type as well as transient ischemic...

author: CHENLA
Matching: relpax eletriptan Find similar documents More document info

66%
PDF
Zomig NS AP Ltr Sep 30.doc page 25


author: CHENLA
Matching: relpax eletriptan Find similar documents More document info

66%
PDF
Eletriptan
1 RELPAX (eletriptan hydrobromide) Tablets DESCRIPTION RELPAX ® (eletriptan) Tablets contain eletriptan hydrobromide, which is a selective 5- hydroxytryptamine 1B/ 1D (5- HT1B/ 1D) receptor agonist
Each RELPAX Tablet for oral administration contains 24.2 or 48.5 mg of eletriptan hydrobromide equivalent to 20 mg or 40 mg of ...

author: CN=Pearl Rawson/O=Pharmaceuticals
Matching: relpax eletriptan Find similar documents More document info

66%
PDF
Eletriptan page 20


author: CN=Pearl Rawson/O=Pharmaceuticals
Matching: relpax eletriptan Find similar documents More document info

66%
PDF
Eletriptan page 19


author: CN=Pearl Rawson/O=Pharmaceuticals
Matching: relpax eletriptan Find similar documents More document info

66%
PDF
Eletriptan page 18


author: CN=Pearl Rawson/O=Pharmaceuticals
Matching: relpax eletriptan Find similar documents More document info

66%
PDF
Eletriptan page 17


author: CN=Pearl Rawson/O=Pharmaceuticals
Matching: relpax eletriptan Find similar documents More document info

66%
PDF
Eletriptan page 16


author: CN=Pearl Rawson/O=Pharmaceuticals
Matching: relpax eletriptan Find similar documents More document info

66%
PDF
Eletriptan page 15


author: CN=Pearl Rawson/O=Pharmaceuticals
Matching: relpax eletriptan Find similar documents More document info

66%
PDF
Eletriptan page 14


author: CN=Pearl Rawson/O=Pharmaceuticals
Matching: relpax eletriptan Find similar documents More document info

66%
PDF
Eletriptan page 13


author: CN=Pearl Rawson/O=Pharmaceuticals
Matching: relpax eletriptan Find similar documents More document info

66%
PDF
Eletriptan page 12


author: CN=Pearl Rawson/O=Pharmaceuticals
Matching: relpax eletriptan Find similar documents More document info


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.